BEXIMCO PHARMA.GDR REGS 1 Tangible Net Worth Ratio
BEXIMCO PHARMA.GDR REGS 1 tangible net worth ratio. BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Tangible Net Worth Ratio of 91.2% as of December 2024. This metric is calculated by deducting intangible assets (€4.72 Billion) from net assets (€53.63 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See R2WA net asset quality index to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of BEXIMCO PHARMA.GDR REGS 1 (2021–2024)
Tangible net worth ratio of BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024. This chart shows how BEXIMCO PHARMA.GDR REGS 1's Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 91.2%, reflecting net assets of €53.63 Billion with intangible assets of €4.72 Billion EUR. See working capital position of BEXIMCO PHARMA.GDR REGS 1 to evaluate short-term liquidity relative to the company's equity base.
BEXIMCO PHARMA.GDR REGS 1 Tangible Net Worth Ratio by Year (2021–2024)
BEXIMCO PHARMA.GDR REGS 1 tangible net worth ratio by year from 2021 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see R2WA company net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.9% | €51.90 Billion | €4.72 Billion | €69.34 Billion | ▲ +0.8 pp |
| 2023 | 90.1% | €47.62 Billion | €4.72 Billion | €69.16 Billion | ▲ +0.7 pp |
| 2022 | 89.4% | €44.64 Billion | €4.73 Billion | €66.15 Billion | ▼ -6.9 pp |
| 2021 | 96.3% | €37.36 Billion | €1.38 Billion | €52.25 Billion | — |